call 911 or your local emergency number if symptoms are severe
Research has found that a high dose of 2.4 mg per week has resulted in clinically meaningful reductions in body weight and waist circumference after both three and six months of treatment when combined with lifestyle modifications, such as dieting and exercise, for managing diabetes and promoting healthy aging among adults with irregular body mass index
Compound-level reported effects BPC-157
The STEP trials, which evaluated once-weekly semaglutide for chronic weight management, showed that patients on 2.4 mg experienced average weight loss of 15% body weight over 68 weeks compared to 2.6% for placebo
If SG and related therapeutics blunt voluntary physical activity via motivational suppression, dampened reward processing, or attenuation of habitual exercise, this could have unintended consequences for long-term energy expenditure, weight maintenance, and preservation of fat-free mass
All of this makes them an excellent intervention for those with type II diabetes mellitus (T2DM), for which they were developed
